XML 39 R32.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Helio Vision Acquisition - Additional Information (Detail) - Helio Vision Inc [Member] $ in Millions | Jan. 28, 2019 USD ($) shares
--- | ---
Business Acquisition [Line Items] |
Business combination, stock issued | shares | 1,407,006
Common Stock after FDA Approval prior to 10th Anniversary [Member] |
Business Acquisition [Line Items] |
Business combination, contingent consideration liability | $ | $ 10.0
Common Stock after FDA Approval Prior to 12th Anniversary [Member] |
Business Acquisition [Line Items] |
Business combination, contingent consideration liability | $ | $ 2.5
Common Stock after FDA Approval Prior to 12th Anniversary [Member] | Maximum [Member] |
Business Acquisition [Line Items] |
Business combination, contingent consideration stock to be issued | shares | 5,248,885
Tax Gross-up Payment in Event of Change of Control or Divesture [Member] | Maximum [Member] |
Business Acquisition [Line Items] |
Business combination, contingent consideration liability | $ | $ 1.0
Founders [Member] |
Business Acquisition [Line Items] |
Business combination, stock issued | shares | 246,562

X
- Definition Business combination, contingent consideration, equity interest issuable, number of shares. + References No definition available. + Details
Name: | aldx_BusinessCombinationContingentConsiderationEquityInterestsIssuableNumberOfShares
Namespace Prefix: | aldx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aldx_HelioVisionIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=aldx_CommonStockAfterFDAApprovalPriorToTenthAnniversaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=aldx_CommonStockAfterFDAApprovalPriorToTwelfthAnniversaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=aldx_TaxGrossUpPaymentChangeOfControlOrDivestureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aldx_FoundersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |